Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
The 28-day countdown starts from the first puncture, and the vial must be discarded after that time
Retatrutide is an investigational peptide drug developed by Eli Lilly that acts as a triple agonist, simultaneously targeting three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Contact La Belle Vie Clinic to schedule your evaluation and take a confident, evidence-based step toward better health
These insights lay the foundation for developing novel therapies targeting energy metabolism in neurodegenerative and metabolic brain conditions, with further preclinical studies planned to assess safety and efficacy
Breaking down the numbers Your 80mg KLOW vial contains 50mg GHK-Cu, 10mg BPC-157, 10mg TB-500, and 10mg KPV
US$ 23.50
US$ 22.07
US$ 24.89
US$ 29.66
US$ 26.20
US$ 25.92
US$ 25.43
US$ 26.76
US$ 21.45
